Will Davis
Contact Details
University Links
- Position
- PhD Student
- Department
- Department of Pathology (Dunedin)
- Qualifications
- BBiomedSc(Hons)
- Research summary
- The emergence of drug tolerant persistors in response to targeted cancer therapy in lung cancer
- Teaching
- Demonstrating PATH201, PATH301, PATH302
- Memberships
- Associate Investigator, Maurice Wilkins Centre for Molecular Discovery (MWC) 2022-present
Research
Patients with lung cancer initially respond dramatically to modern therapies, including targeted therapies. Unfortunately, these responses are often short-lived due to the development of drug tolerance and resistance. My research focuses on understanding how lung adenocarcinomas escape from targeted therapy via the phenomenon of drug tolerance. I am particularly interested in the involvement of long non-coding RNAs (lncRNAs) in this process.